Research programme: Marburg virus DNA vaccine - Cyto Pulse/USAMRIID
Latest Information Update: 16 Jul 2016
At a glance
- Originator Cyto Pulse Sciences; United States Army Medical Research Institute of Infectious Diseases
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Marburg virus disease
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Marburg virus disease in USA